Anúncio
Anúncio
FBIO
Fortress Biotech, Inc.
4.32
USDPatrocinado
-0.06
-1.46%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
4.40
+0.08
+1.95%
Relatórios de Lucros FBIO
Rácio de surpresa positiva
FBIO separação 23 de 39 últimas estimativas.
59%
Próximo Relatório
Data do Próximo Relatório
24 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$23.61M
/-$0.35
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+33.90%
/-418.18%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+56.14%
/-53.33%
Fortress Biotech, Inc. earnings per share and revenue
On 14 de nov. de 2025, FBIO reported earnings of 0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.42 USD, resulting in a 125.68% surprise. Revenue reached 17.63 milhão, compared to an expected 21.44 milhão, with a -17.76% difference. The market reacted with a +5.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.35 USD, with revenue projected to reach 23.61 milhão USD, implying an diminuir of -418.18% EPS, and aumentar of 33.90% in Revenue from the last quarter.
FAQ
What were Fortress Biotech, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Fortress Biotech, Inc. reported EPS of $0.11, beating estimates by 125.68%, and revenue of $17.63M, -17.76% below expectations.
How did the market react to Fortress Biotech, Inc.'s Q3 2025 earnings?
The stock price moved up 5.22%, changed from $2.49 before the earnings release to $2.62 the day after.
When is Fortress Biotech, Inc. expected to report next?
The next earning report is scheduled for 24 de mar. de 2026.
What are the forecasts for Fortress Biotech, Inc.'s next earnings report?
Based on 4
analistas, Fortress Biotech, Inc. is expected to report EPS of -$0.35 and revenue of $23.61M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio